
Forcyte Biotechnologies
Forcyte Biotechnologies is a YC Winter 2021 (W21) company. Based in Los Angeles, CA, USA. Team of 5.
About Forcyte Biotechnologies
Summary
Forcyte Biotechnologies discovers drugs that regulate cellular contraction to treat mechanical diseases such as asthma, fibrosis, hypertension, and preterm labor. The company uses patented bioMEMS technology to measure cell contractile force as a quantifiable metric, enabling high-throughput screening of hundreds of thousands of drug candidates across multiple human cell types. This approach replaces conventional drug discovery methods that lack a direct readout of the mechanical behavior driving these conditions.
From the Y Combinator listing
Discover drugs that control how much cells "squeeze" to treat disease
In a nutshell: many diseases are caused by how much your cells squeeze (asthma, fibrosis, others). We discover drugs that control how much cells squeeze, with ease, to treat disease. We use patented bioMEMS technology to turn cell strength (cells' ability to pull/ squeeze) into a quantifiable metric in drug discovery, to help find better drugs for mechanical diseases. We screen 100,000s of drugs against numerous contractile human cell types to comprehensively map human mechanobiology (the "contractome") and identify promising drug development starting points to deliver novel medicines to treat mechanically-driven diseases including asthma, hypertension, preterm labor, fibrosis, and others.
Facts
- Healthcare / Healthcare -> Diagnostics
- Los Angeles, CA, USA
- 5
- Active
- Early
Founders (2)
- Ivan Pushkarsky
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works